nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—MTOR—hypertension	0.415	1	CbGaD
Everolimus—CYP3A4—Guanethidine—hypertension	0.023	0.11	CbGbCtD
Everolimus—CYP3A4—Hydralazine—hypertension	0.0175	0.0837	CbGbCtD
Everolimus—CYP3A4—Guanfacine—hypertension	0.0149	0.0712	CbGbCtD
Everolimus—CYP3A4—Isradipine—hypertension	0.0132	0.0634	CbGbCtD
Everolimus—CYP3A4—Indapamide—hypertension	0.0117	0.0558	CbGbCtD
Everolimus—CYP3A4—Nisoldipine—hypertension	0.0117	0.0558	CbGbCtD
Everolimus—CYP3A4—Eplerenone—hypertension	0.0113	0.0539	CbGbCtD
Everolimus—CYP3A4—Diltiazem—hypertension	0.0113	0.0539	CbGbCtD
Everolimus—CYP3A4—Enalapril—hypertension	0.01	0.0481	CbGbCtD
Everolimus—CYP3A4—Irbesartan—hypertension	0.00917	0.044	CbGbCtD
Everolimus—CYP3A4—Amlodipine—hypertension	0.009	0.0431	CbGbCtD
Everolimus—CYP3A4—Felodipine—hypertension	0.00868	0.0416	CbGbCtD
Everolimus—CYP3A4—Nifedipine—hypertension	0.00839	0.0402	CbGbCtD
Everolimus—CYP3A4—Nicardipine—hypertension	0.00826	0.0396	CbGbCtD
Everolimus—CYP3A4—Carvedilol—hypertension	0.00826	0.0396	CbGbCtD
Everolimus—CYP3A4—Propranolol—hypertension	0.0076	0.0364	CbGbCtD
Everolimus—CYP3A4—Clonidine—hypertension	0.00725	0.0348	CbGbCtD
Everolimus—CYP3A4—Atorvastatin—hypertension	0.00646	0.031	CbGbCtD
Everolimus—CYP3A4—Losartan—hypertension	0.00591	0.0283	CbGbCtD
Everolimus—CYP3A4—Verapamil—hypertension	0.00522	0.025	CbGbCtD
Everolimus—MTOR—hindlimb—hypertension	0.00518	0.162	CbGeAlD
Everolimus—MTOR—blood vessel—hypertension	0.00247	0.0774	CbGeAlD
Everolimus—FKBP1A—cardiac ventricle—hypertension	0.0016	0.0501	CbGeAlD
Everolimus—FKBP1A—myocardium—hypertension	0.00151	0.0471	CbGeAlD
Everolimus—MTOR—brainstem—hypertension	0.00135	0.0423	CbGeAlD
Everolimus—CYP3A4—urine—hypertension	0.00134	0.042	CbGeAlD
Everolimus—MTOR—heart—hypertension	0.00117	0.0366	CbGeAlD
Everolimus—MTOR—smooth muscle tissue—hypertension	0.00116	0.0363	CbGeAlD
Everolimus—MTOR—cardiovascular system—hypertension	0.0011	0.0345	CbGeAlD
Everolimus—FKBP1A—adrenal cortex—hypertension	0.00109	0.034	CbGeAlD
Everolimus—MTOR—kidney—hypertension	0.00108	0.0338	CbGeAlD
Everolimus—FKBP1A—heart—hypertension	0.00105	0.0329	CbGeAlD
Everolimus—FKBP1A—smooth muscle tissue—hypertension	0.00104	0.0326	CbGeAlD
Everolimus—FKBP1A—decidua—hypertension	0.00102	0.032	CbGeAlD
Everolimus—FKBP1A—cardiovascular system—hypertension	0.000992	0.031	CbGeAlD
Everolimus—FKBP1A—kidney—hypertension	0.000971	0.0304	CbGeAlD
Everolimus—Pimecrolimus—MTOR—hypertension	0.000969	0.218	CrCbGaD
Everolimus—FKBP1A—cortex of kidney—hypertension	0.000946	0.0296	CbGeAlD
Everolimus—FKBP1A—cardiac atrium—hypertension	0.0009	0.0281	CbGeAlD
Everolimus—MTOR—adrenal gland—hypertension	0.000873	0.0273	CbGeAlD
Everolimus—FKBP1A—medulla oblongata—hypertension	0.000848	0.0265	CbGeAlD
Everolimus—FKBP1A—adrenal gland—hypertension	0.000785	0.0246	CbGeAlD
Everolimus—MTOR—endocrine gland—hypertension	0.000757	0.0237	CbGeAlD
Everolimus—Sirolimus—FGF2—hypertension	0.000707	0.159	CrCbGaD
Everolimus—MTOR—central nervous system—hypertension	0.000682	0.0213	CbGeAlD
Everolimus—FKBP1A—endocrine gland—hypertension	0.000681	0.0213	CbGeAlD
Everolimus—Temsirolimus—MTOR—hypertension	0.000655	0.147	CrCbGaD
Everolimus—FKBP1A—central nervous system—hypertension	0.000613	0.0192	CbGeAlD
Everolimus—Tacrolimus—MTOR—hypertension	0.000576	0.13	CrCbGaD
Everolimus—Sirolimus—MTOR—hypertension	0.000576	0.13	CrCbGaD
Everolimus—CYP3A4—kidney—hypertension	0.000317	0.00993	CbGeAlD
Everolimus—Temsirolimus—CYP3A5—hypertension	0.000312	0.0702	CrCbGaD
Everolimus—Tacrolimus—CYP3A5—hypertension	0.000275	0.0618	CrCbGaD
Everolimus—Sirolimus—CYP3A5—hypertension	0.000275	0.0618	CrCbGaD
Everolimus—CYP3A4—endocrine gland—hypertension	0.000222	0.00696	CbGeAlD
Everolimus—CYP3A4—central nervous system—hypertension	0.0002	0.00627	CbGeAlD
Everolimus—Tacrolimus—ALB—hypertension	0.000104	0.0233	CrCbGaD
Everolimus—Palpitations—Lisinopril—hypertension	1.59e-05	7.37e-05	CcSEcCtD
Everolimus—Diarrhoea—Olmesartan—hypertension	1.59e-05	7.36e-05	CcSEcCtD
Everolimus—Headache—Eplerenone—hypertension	1.59e-05	7.36e-05	CcSEcCtD
Everolimus—Rash—Nifedipine—hypertension	1.59e-05	7.36e-05	CcSEcCtD
Everolimus—Nervous system disorder—Ramipril—hypertension	1.59e-05	7.36e-05	CcSEcCtD
Everolimus—Dermatitis—Nifedipine—hypertension	1.59e-05	7.35e-05	CcSEcCtD
Everolimus—Abdominal pain—Irbesartan—hypertension	1.59e-05	7.35e-05	CcSEcCtD
Everolimus—Body temperature increased—Irbesartan—hypertension	1.59e-05	7.35e-05	CcSEcCtD
Everolimus—Thrombocytopenia—Ramipril—hypertension	1.59e-05	7.34e-05	CcSEcCtD
Everolimus—Oedema—Timolol—hypertension	1.59e-05	7.33e-05	CcSEcCtD
Everolimus—Loss of consciousness—Lisinopril—hypertension	1.58e-05	7.33e-05	CcSEcCtD
Everolimus—Rash—Verapamil—hypertension	1.58e-05	7.32e-05	CcSEcCtD
Everolimus—Tachycardia—Ramipril—hypertension	1.58e-05	7.32e-05	CcSEcCtD
Everolimus—Dermatitis—Verapamil—hypertension	1.58e-05	7.32e-05	CcSEcCtD
Everolimus—Headache—Nifedipine—hypertension	1.58e-05	7.31e-05	CcSEcCtD
Everolimus—Pruritus—Clonidine—hypertension	1.58e-05	7.29e-05	CcSEcCtD
Everolimus—Abdominal pain—Hydrochlorothiazide—hypertension	1.58e-05	7.29e-05	CcSEcCtD
Everolimus—Body temperature increased—Hydrochlorothiazide—hypertension	1.58e-05	7.29e-05	CcSEcCtD
Everolimus—Skin disorder—Ramipril—hypertension	1.58e-05	7.29e-05	CcSEcCtD
Everolimus—Infection—Timolol—hypertension	1.58e-05	7.28e-05	CcSEcCtD
Everolimus—Headache—Verapamil—hypertension	1.57e-05	7.28e-05	CcSEcCtD
Everolimus—Hypersensitivity—Telmisartan—hypertension	1.57e-05	7.28e-05	CcSEcCtD
Everolimus—Cough—Lisinopril—hypertension	1.57e-05	7.27e-05	CcSEcCtD
Everolimus—Nausea—Indapamide—hypertension	1.57e-05	7.26e-05	CcSEcCtD
Everolimus—Nausea—Diltiazem—hypertension	1.57e-05	7.26e-05	CcSEcCtD
Everolimus—Hyperhidrosis—Ramipril—hypertension	1.57e-05	7.25e-05	CcSEcCtD
Everolimus—Asthenia—Trandolapril—hypertension	1.56e-05	7.21e-05	CcSEcCtD
Everolimus—Shock—Timolol—hypertension	1.56e-05	7.21e-05	CcSEcCtD
Everolimus—Feeling abnormal—Losartan—hypertension	1.56e-05	7.21e-05	CcSEcCtD
Everolimus—Nervous system disorder—Timolol—hypertension	1.56e-05	7.19e-05	CcSEcCtD
Everolimus—Nausea—Carvedilol—hypertension	1.56e-05	7.19e-05	CcSEcCtD
Everolimus—Asthenia—Enalapril—hypertension	1.55e-05	7.19e-05	CcSEcCtD
Everolimus—Abdominal pain—Furosemide—hypertension	1.55e-05	7.17e-05	CcSEcCtD
Everolimus—Body temperature increased—Furosemide—hypertension	1.55e-05	7.17e-05	CcSEcCtD
Everolimus—Gastrointestinal pain—Losartan—hypertension	1.55e-05	7.15e-05	CcSEcCtD
Everolimus—Dizziness—Valsartan—hypertension	1.55e-05	7.15e-05	CcSEcCtD
Everolimus—Anorexia—Ramipril—hypertension	1.55e-05	7.15e-05	CcSEcCtD
Everolimus—Skin disorder—Timolol—hypertension	1.54e-05	7.12e-05	CcSEcCtD
Everolimus—Dizziness—Olmesartan—hypertension	1.54e-05	7.12e-05	CcSEcCtD
Everolimus—Pruritus—Trandolapril—hypertension	1.54e-05	7.11e-05	CcSEcCtD
Everolimus—Nausea—Doxazosin—hypertension	1.54e-05	7.11e-05	CcSEcCtD
Everolimus—Chest pain—Lisinopril—hypertension	1.54e-05	7.1e-05	CcSEcCtD
Everolimus—Myalgia—Lisinopril—hypertension	1.54e-05	7.1e-05	CcSEcCtD
Everolimus—Arthralgia—Lisinopril—hypertension	1.54e-05	7.1e-05	CcSEcCtD
Everolimus—Body temperature increased—Betaxolol—hypertension	1.54e-05	7.1e-05	CcSEcCtD
Everolimus—Hyperhidrosis—Timolol—hypertension	1.53e-05	7.09e-05	CcSEcCtD
Everolimus—Asthenia—Telmisartan—hypertension	1.53e-05	7.09e-05	CcSEcCtD
Everolimus—Pruritus—Enalapril—hypertension	1.53e-05	7.09e-05	CcSEcCtD
Everolimus—Anxiety—Lisinopril—hypertension	1.53e-05	7.07e-05	CcSEcCtD
Everolimus—Diarrhoea—Clonidine—hypertension	1.53e-05	7.05e-05	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	1.52e-05	7.05e-05	CcSEcCtD
Everolimus—Nausea—Fosinopril—hypertension	1.52e-05	7.02e-05	CcSEcCtD
Everolimus—Discomfort—Lisinopril—hypertension	1.52e-05	7.01e-05	CcSEcCtD
Everolimus—Hypotension—Ramipril—hypertension	1.52e-05	7.01e-05	CcSEcCtD
Everolimus—Anorexia—Timolol—hypertension	1.51e-05	6.99e-05	CcSEcCtD
Everolimus—Pruritus—Telmisartan—hypertension	1.51e-05	6.99e-05	CcSEcCtD
Everolimus—Nausea—Eplerenone—hypertension	1.51e-05	6.98e-05	CcSEcCtD
Everolimus—Dry mouth—Lisinopril—hypertension	1.5e-05	6.94e-05	CcSEcCtD
Everolimus—Nausea—Nifedipine—hypertension	1.5e-05	6.93e-05	CcSEcCtD
Everolimus—Body temperature increased—Losartan—hypertension	1.5e-05	6.92e-05	CcSEcCtD
Everolimus—Abdominal pain—Losartan—hypertension	1.5e-05	6.92e-05	CcSEcCtD
Everolimus—Nausea—Verapamil—hypertension	1.49e-05	6.9e-05	CcSEcCtD
Everolimus—Asthenia—Captopril—hypertension	1.49e-05	6.89e-05	CcSEcCtD
Everolimus—Diarrhoea—Trandolapril—hypertension	1.49e-05	6.88e-05	CcSEcCtD
Everolimus—Vomiting—Valsartan—hypertension	1.49e-05	6.88e-05	CcSEcCtD
Everolimus—Diarrhoea—Enalapril—hypertension	1.48e-05	6.85e-05	CcSEcCtD
Everolimus—Hypotension—Timolol—hypertension	1.48e-05	6.85e-05	CcSEcCtD
Everolimus—Hypersensitivity—Irbesartan—hypertension	1.48e-05	6.85e-05	CcSEcCtD
Everolimus—Vomiting—Olmesartan—hypertension	1.48e-05	6.84e-05	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Ramipril—hypertension	1.48e-05	6.83e-05	CcSEcCtD
Everolimus—Rash—Valsartan—hypertension	1.48e-05	6.82e-05	CcSEcCtD
Everolimus—Dizziness—Clonidine—hypertension	1.47e-05	6.82e-05	CcSEcCtD
Everolimus—Dermatitis—Valsartan—hypertension	1.47e-05	6.81e-05	CcSEcCtD
Everolimus—Oedema—Lisinopril—hypertension	1.47e-05	6.8e-05	CcSEcCtD
Everolimus—Pruritus—Captopril—hypertension	1.47e-05	6.8e-05	CcSEcCtD
Everolimus—Hypersensitivity—Hydrochlorothiazide—hypertension	1.47e-05	6.79e-05	CcSEcCtD
Everolimus—Rash—Olmesartan—hypertension	1.47e-05	6.79e-05	CcSEcCtD
Everolimus—Insomnia—Ramipril—hypertension	1.47e-05	6.78e-05	CcSEcCtD
Everolimus—Dermatitis—Olmesartan—hypertension	1.47e-05	6.78e-05	CcSEcCtD
Everolimus—Headache—Valsartan—hypertension	1.47e-05	6.78e-05	CcSEcCtD
Everolimus—Diarrhoea—Telmisartan—hypertension	1.46e-05	6.76e-05	CcSEcCtD
Everolimus—Infection—Lisinopril—hypertension	1.46e-05	6.76e-05	CcSEcCtD
Everolimus—Headache—Olmesartan—hypertension	1.46e-05	6.74e-05	CcSEcCtD
Everolimus—Paraesthesia—Ramipril—hypertension	1.46e-05	6.74e-05	CcSEcCtD
Everolimus—Shock—Lisinopril—hypertension	1.45e-05	6.69e-05	CcSEcCtD
Everolimus—Asthenia—Perindopril—hypertension	1.45e-05	6.69e-05	CcSEcCtD
Everolimus—Dyspnoea—Ramipril—hypertension	1.45e-05	6.69e-05	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Timolol—hypertension	1.45e-05	6.68e-05	CcSEcCtD
Everolimus—Hypersensitivity—Furosemide—hypertension	1.45e-05	6.68e-05	CcSEcCtD
Everolimus—Asthenia—Irbesartan—hypertension	1.44e-05	6.67e-05	CcSEcCtD
Everolimus—Somnolence—Ramipril—hypertension	1.44e-05	6.67e-05	CcSEcCtD
Everolimus—Thrombocytopenia—Lisinopril—hypertension	1.44e-05	6.66e-05	CcSEcCtD
Everolimus—Dizziness—Trandolapril—hypertension	1.44e-05	6.65e-05	CcSEcCtD
Everolimus—Tachycardia—Lisinopril—hypertension	1.44e-05	6.64e-05	CcSEcCtD
Everolimus—Insomnia—Timolol—hypertension	1.43e-05	6.63e-05	CcSEcCtD
Everolimus—Dizziness—Enalapril—hypertension	1.43e-05	6.62e-05	CcSEcCtD
Everolimus—Asthenia—Hydrochlorothiazide—hypertension	1.43e-05	6.61e-05	CcSEcCtD
Everolimus—Hypersensitivity—Betaxolol—hypertension	1.43e-05	6.61e-05	CcSEcCtD
Everolimus—Skin disorder—Lisinopril—hypertension	1.43e-05	6.61e-05	CcSEcCtD
Everolimus—Dyspepsia—Ramipril—hypertension	1.43e-05	6.6e-05	CcSEcCtD
Everolimus—Pruritus—Perindopril—hypertension	1.43e-05	6.6e-05	CcSEcCtD
Everolimus—Paraesthesia—Timolol—hypertension	1.42e-05	6.58e-05	CcSEcCtD
Everolimus—Pruritus—Irbesartan—hypertension	1.42e-05	6.58e-05	CcSEcCtD
Everolimus—Hyperhidrosis—Lisinopril—hypertension	1.42e-05	6.58e-05	CcSEcCtD
Everolimus—Diarrhoea—Captopril—hypertension	1.42e-05	6.57e-05	CcSEcCtD
Everolimus—Vomiting—Clonidine—hypertension	1.42e-05	6.56e-05	CcSEcCtD
Everolimus—Dyspnoea—Timolol—hypertension	1.41e-05	6.54e-05	CcSEcCtD
Everolimus—Dizziness—Telmisartan—hypertension	1.41e-05	6.53e-05	CcSEcCtD
Everolimus—Pruritus—Hydrochlorothiazide—hypertension	1.41e-05	6.52e-05	CcSEcCtD
Everolimus—Decreased appetite—Ramipril—hypertension	1.41e-05	6.52e-05	CcSEcCtD
Everolimus—Somnolence—Timolol—hypertension	1.41e-05	6.52e-05	CcSEcCtD
Everolimus—Asthenia—Furosemide—hypertension	1.41e-05	6.5e-05	CcSEcCtD
Everolimus—Rash—Clonidine—hypertension	1.41e-05	6.5e-05	CcSEcCtD
Everolimus—Dermatitis—Clonidine—hypertension	1.41e-05	6.49e-05	CcSEcCtD
Everolimus—Anorexia—Lisinopril—hypertension	1.4e-05	6.48e-05	CcSEcCtD
Everolimus—Gastrointestinal disorder—Ramipril—hypertension	1.4e-05	6.48e-05	CcSEcCtD
Everolimus—Fatigue—Ramipril—hypertension	1.4e-05	6.47e-05	CcSEcCtD
Everolimus—Headache—Clonidine—hypertension	1.4e-05	6.46e-05	CcSEcCtD
Everolimus—Dyspepsia—Timolol—hypertension	1.4e-05	6.45e-05	CcSEcCtD
Everolimus—Hypersensitivity—Losartan—hypertension	1.39e-05	6.44e-05	CcSEcCtD
Everolimus—Asthenia—Betaxolol—hypertension	1.39e-05	6.44e-05	CcSEcCtD
Everolimus—Nausea—Valsartan—hypertension	1.39e-05	6.42e-05	CcSEcCtD
Everolimus—Pruritus—Furosemide—hypertension	1.39e-05	6.41e-05	CcSEcCtD
Everolimus—Constipation—Ramipril—hypertension	1.39e-05	6.41e-05	CcSEcCtD
Everolimus—Nausea—Olmesartan—hypertension	1.38e-05	6.39e-05	CcSEcCtD
Everolimus—Vomiting—Trandolapril—hypertension	1.38e-05	6.39e-05	CcSEcCtD
Everolimus—Diarrhoea—Perindopril—hypertension	1.38e-05	6.38e-05	CcSEcCtD
Everolimus—Decreased appetite—Timolol—hypertension	1.38e-05	6.37e-05	CcSEcCtD
Everolimus—Vomiting—Enalapril—hypertension	1.38e-05	6.37e-05	CcSEcCtD
Everolimus—Diarrhoea—Irbesartan—hypertension	1.38e-05	6.36e-05	CcSEcCtD
Everolimus—Hypotension—Lisinopril—hypertension	1.38e-05	6.36e-05	CcSEcCtD
Everolimus—Dizziness—Captopril—hypertension	1.37e-05	6.35e-05	CcSEcCtD
Everolimus—Pruritus—Betaxolol—hypertension	1.37e-05	6.35e-05	CcSEcCtD
Everolimus—Rash—Trandolapril—hypertension	1.37e-05	6.34e-05	CcSEcCtD
Everolimus—Dermatitis—Trandolapril—hypertension	1.37e-05	6.33e-05	CcSEcCtD
Everolimus—Gastrointestinal disorder—Timolol—hypertension	1.37e-05	6.33e-05	CcSEcCtD
Everolimus—Fatigue—Timolol—hypertension	1.37e-05	6.32e-05	CcSEcCtD
Everolimus—Rash—Enalapril—hypertension	1.37e-05	6.31e-05	CcSEcCtD
Everolimus—Dermatitis—Enalapril—hypertension	1.36e-05	6.31e-05	CcSEcCtD
Everolimus—Diarrhoea—Hydrochlorothiazide—hypertension	1.36e-05	6.31e-05	CcSEcCtD
Everolimus—Headache—Trandolapril—hypertension	1.36e-05	6.3e-05	CcSEcCtD
Everolimus—Vomiting—Telmisartan—hypertension	1.36e-05	6.28e-05	CcSEcCtD
Everolimus—Asthenia—Losartan—hypertension	1.36e-05	6.28e-05	CcSEcCtD
Everolimus—Headache—Enalapril—hypertension	1.36e-05	6.27e-05	CcSEcCtD
Everolimus—Pain—Timolol—hypertension	1.36e-05	6.27e-05	CcSEcCtD
Everolimus—Rash—Telmisartan—hypertension	1.35e-05	6.23e-05	CcSEcCtD
Everolimus—Dermatitis—Telmisartan—hypertension	1.35e-05	6.22e-05	CcSEcCtD
Everolimus—Diarrhoea—Furosemide—hypertension	1.34e-05	6.2e-05	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Lisinopril—hypertension	1.34e-05	6.2e-05	CcSEcCtD
Everolimus—Pruritus—Losartan—hypertension	1.34e-05	6.19e-05	CcSEcCtD
Everolimus—Headache—Telmisartan—hypertension	1.34e-05	6.19e-05	CcSEcCtD
Everolimus—Feeling abnormal—Ramipril—hypertension	1.34e-05	6.18e-05	CcSEcCtD
Everolimus—Dizziness—Perindopril—hypertension	1.33e-05	6.17e-05	CcSEcCtD
Everolimus—Insomnia—Lisinopril—hypertension	1.33e-05	6.15e-05	CcSEcCtD
Everolimus—Dizziness—Irbesartan—hypertension	1.33e-05	6.15e-05	CcSEcCtD
Everolimus—Diarrhoea—Betaxolol—hypertension	1.33e-05	6.14e-05	CcSEcCtD
Everolimus—Gastrointestinal pain—Ramipril—hypertension	1.33e-05	6.13e-05	CcSEcCtD
Everolimus—Nausea—Clonidine—hypertension	1.32e-05	6.12e-05	CcSEcCtD
Everolimus—Paraesthesia—Lisinopril—hypertension	1.32e-05	6.11e-05	CcSEcCtD
Everolimus—Vomiting—Captopril—hypertension	1.32e-05	6.11e-05	CcSEcCtD
Everolimus—Dizziness—Hydrochlorothiazide—hypertension	1.32e-05	6.1e-05	CcSEcCtD
Everolimus—Dyspnoea—Lisinopril—hypertension	1.31e-05	6.06e-05	CcSEcCtD
Everolimus—Rash—Captopril—hypertension	1.31e-05	6.06e-05	CcSEcCtD
Everolimus—Dermatitis—Captopril—hypertension	1.31e-05	6.05e-05	CcSEcCtD
Everolimus—Somnolence—Lisinopril—hypertension	1.31e-05	6.05e-05	CcSEcCtD
Everolimus—Feeling abnormal—Timolol—hypertension	1.31e-05	6.04e-05	CcSEcCtD
Everolimus—Headache—Captopril—hypertension	1.3e-05	6.02e-05	CcSEcCtD
Everolimus—Gastrointestinal pain—Timolol—hypertension	1.3e-05	6e-05	CcSEcCtD
Everolimus—Dizziness—Furosemide—hypertension	1.3e-05	6e-05	CcSEcCtD
Everolimus—Dyspepsia—Lisinopril—hypertension	1.3e-05	5.99e-05	CcSEcCtD
Everolimus—Diarrhoea—Losartan—hypertension	1.29e-05	5.99e-05	CcSEcCtD
Everolimus—Nausea—Trandolapril—hypertension	1.29e-05	5.97e-05	CcSEcCtD
Everolimus—Nausea—Enalapril—hypertension	1.29e-05	5.95e-05	CcSEcCtD
Everolimus—Dizziness—Betaxolol—hypertension	1.28e-05	5.94e-05	CcSEcCtD
Everolimus—Vomiting—Perindopril—hypertension	1.28e-05	5.93e-05	CcSEcCtD
Everolimus—Abdominal pain—Ramipril—hypertension	1.28e-05	5.93e-05	CcSEcCtD
Everolimus—Body temperature increased—Ramipril—hypertension	1.28e-05	5.93e-05	CcSEcCtD
Everolimus—Decreased appetite—Lisinopril—hypertension	1.28e-05	5.91e-05	CcSEcCtD
Everolimus—Vomiting—Irbesartan—hypertension	1.28e-05	5.91e-05	CcSEcCtD
Everolimus—Rash—Perindopril—hypertension	1.27e-05	5.88e-05	CcSEcCtD
Everolimus—Dermatitis—Perindopril—hypertension	1.27e-05	5.87e-05	CcSEcCtD
Everolimus—Gastrointestinal disorder—Lisinopril—hypertension	1.27e-05	5.87e-05	CcSEcCtD
Everolimus—Nausea—Telmisartan—hypertension	1.27e-05	5.87e-05	CcSEcCtD
Everolimus—Fatigue—Lisinopril—hypertension	1.27e-05	5.86e-05	CcSEcCtD
Everolimus—Vomiting—Hydrochlorothiazide—hypertension	1.27e-05	5.86e-05	CcSEcCtD
Everolimus—Rash—Irbesartan—hypertension	1.27e-05	5.86e-05	CcSEcCtD
Everolimus—Dermatitis—Irbesartan—hypertension	1.27e-05	5.86e-05	CcSEcCtD
Everolimus—Headache—Perindopril—hypertension	1.26e-05	5.84e-05	CcSEcCtD
Everolimus—Headache—Irbesartan—hypertension	1.26e-05	5.82e-05	CcSEcCtD
Everolimus—Pain—Lisinopril—hypertension	1.26e-05	5.82e-05	CcSEcCtD
Everolimus—Constipation—Lisinopril—hypertension	1.26e-05	5.82e-05	CcSEcCtD
Everolimus—Rash—Hydrochlorothiazide—hypertension	1.26e-05	5.81e-05	CcSEcCtD
Everolimus—Dermatitis—Hydrochlorothiazide—hypertension	1.26e-05	5.81e-05	CcSEcCtD
Everolimus—Abdominal pain—Timolol—hypertension	1.25e-05	5.8e-05	CcSEcCtD
Everolimus—Body temperature increased—Timolol—hypertension	1.25e-05	5.8e-05	CcSEcCtD
Everolimus—Dizziness—Losartan—hypertension	1.25e-05	5.78e-05	CcSEcCtD
Everolimus—Headache—Hydrochlorothiazide—hypertension	1.25e-05	5.78e-05	CcSEcCtD
Everolimus—Vomiting—Furosemide—hypertension	1.25e-05	5.76e-05	CcSEcCtD
Everolimus—Rash—Furosemide—hypertension	1.24e-05	5.72e-05	CcSEcCtD
Everolimus—Dermatitis—Furosemide—hypertension	1.24e-05	5.71e-05	CcSEcCtD
Everolimus—Vomiting—Betaxolol—hypertension	1.23e-05	5.71e-05	CcSEcCtD
Everolimus—Nausea—Captopril—hypertension	1.23e-05	5.71e-05	CcSEcCtD
Everolimus—Headache—Furosemide—hypertension	1.23e-05	5.68e-05	CcSEcCtD
Everolimus—Rash—Betaxolol—hypertension	1.22e-05	5.66e-05	CcSEcCtD
Everolimus—Dermatitis—Betaxolol—hypertension	1.22e-05	5.65e-05	CcSEcCtD
Everolimus—Headache—Betaxolol—hypertension	1.22e-05	5.62e-05	CcSEcCtD
Everolimus—Feeling abnormal—Lisinopril—hypertension	1.21e-05	5.61e-05	CcSEcCtD
Everolimus—Gastrointestinal pain—Lisinopril—hypertension	1.2e-05	5.56e-05	CcSEcCtD
Everolimus—Vomiting—Losartan—hypertension	1.2e-05	5.56e-05	CcSEcCtD
Everolimus—Nausea—Perindopril—hypertension	1.2e-05	5.54e-05	CcSEcCtD
Everolimus—Hypersensitivity—Ramipril—hypertension	1.2e-05	5.53e-05	CcSEcCtD
Everolimus—Nausea—Irbesartan—hypertension	1.19e-05	5.52e-05	CcSEcCtD
Everolimus—Rash—Losartan—hypertension	1.19e-05	5.52e-05	CcSEcCtD
Everolimus—Dermatitis—Losartan—hypertension	1.19e-05	5.51e-05	CcSEcCtD
Everolimus—Headache—Losartan—hypertension	1.19e-05	5.48e-05	CcSEcCtD
Everolimus—Nausea—Hydrochlorothiazide—hypertension	1.18e-05	5.48e-05	CcSEcCtD
Everolimus—Hypersensitivity—Timolol—hypertension	1.17e-05	5.4e-05	CcSEcCtD
Everolimus—Nausea—Furosemide—hypertension	1.17e-05	5.39e-05	CcSEcCtD
Everolimus—Asthenia—Ramipril—hypertension	1.16e-05	5.38e-05	CcSEcCtD
Everolimus—Body temperature increased—Lisinopril—hypertension	1.16e-05	5.38e-05	CcSEcCtD
Everolimus—Abdominal pain—Lisinopril—hypertension	1.16e-05	5.38e-05	CcSEcCtD
Everolimus—Nausea—Betaxolol—hypertension	1.15e-05	5.33e-05	CcSEcCtD
Everolimus—Pruritus—Ramipril—hypertension	1.15e-05	5.31e-05	CcSEcCtD
Everolimus—Asthenia—Timolol—hypertension	1.14e-05	5.26e-05	CcSEcCtD
Everolimus—Nausea—Losartan—hypertension	1.12e-05	5.2e-05	CcSEcCtD
Everolimus—Pruritus—Timolol—hypertension	1.12e-05	5.19e-05	CcSEcCtD
Everolimus—Diarrhoea—Ramipril—hypertension	1.11e-05	5.13e-05	CcSEcCtD
Everolimus—Diarrhoea—Timolol—hypertension	1.09e-05	5.02e-05	CcSEcCtD
Everolimus—Hypersensitivity—Lisinopril—hypertension	1.08e-05	5.01e-05	CcSEcCtD
Everolimus—Dizziness—Ramipril—hypertension	1.07e-05	4.96e-05	CcSEcCtD
Everolimus—Asthenia—Lisinopril—hypertension	1.06e-05	4.88e-05	CcSEcCtD
Everolimus—Dizziness—Timolol—hypertension	1.05e-05	4.85e-05	CcSEcCtD
Everolimus—Pruritus—Lisinopril—hypertension	1.04e-05	4.81e-05	CcSEcCtD
Everolimus—Vomiting—Ramipril—hypertension	1.03e-05	4.77e-05	CcSEcCtD
Everolimus—Rash—Ramipril—hypertension	1.02e-05	4.73e-05	CcSEcCtD
Everolimus—Dermatitis—Ramipril—hypertension	1.02e-05	4.72e-05	CcSEcCtD
Everolimus—Headache—Ramipril—hypertension	1.02e-05	4.7e-05	CcSEcCtD
Everolimus—Vomiting—Timolol—hypertension	1.01e-05	4.66e-05	CcSEcCtD
Everolimus—Diarrhoea—Lisinopril—hypertension	1.01e-05	4.65e-05	CcSEcCtD
Everolimus—Rash—Timolol—hypertension	1e-05	4.62e-05	CcSEcCtD
Everolimus—Dermatitis—Timolol—hypertension	9.99e-06	4.62e-05	CcSEcCtD
Everolimus—Headache—Timolol—hypertension	9.94e-06	4.59e-05	CcSEcCtD
Everolimus—Dizziness—Lisinopril—hypertension	9.73e-06	4.5e-05	CcSEcCtD
Everolimus—Nausea—Ramipril—hypertension	9.64e-06	4.46e-05	CcSEcCtD
Everolimus—Nausea—Timolol—hypertension	9.42e-06	4.36e-05	CcSEcCtD
Everolimus—Vomiting—Lisinopril—hypertension	9.36e-06	4.33e-05	CcSEcCtD
Everolimus—Rash—Lisinopril—hypertension	9.28e-06	4.29e-05	CcSEcCtD
Everolimus—Dermatitis—Lisinopril—hypertension	9.27e-06	4.29e-05	CcSEcCtD
Everolimus—Headache—Lisinopril—hypertension	9.22e-06	4.26e-05	CcSEcCtD
Everolimus—Nausea—Lisinopril—hypertension	8.74e-06	4.04e-05	CcSEcCtD
Everolimus—MTOR—Disease—CALM1—hypertension	6.28e-06	5.07e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HDAC1—hypertension	6.26e-06	5.06e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—STK11—hypertension	6.26e-06	5.06e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—APOE—hypertension	6.26e-06	5.06e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MDH1—hypertension	6.24e-06	5.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTT2—hypertension	6.24e-06	5.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HYAL1—hypertension	6.24e-06	5.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CDO1—hypertension	6.24e-06	5.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CPS1—hypertension	6.24e-06	5.04e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL10—hypertension	6.21e-06	5.02e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—CAV1—hypertension	6.2e-06	5.01e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PLG—hypertension	6.19e-06	5e-05	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—SRC—hypertension	6.19e-06	5e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—APOA1—hypertension	6.19e-06	5e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—SRC—hypertension	6.17e-06	4.98e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SERPINE1—hypertension	6.11e-06	4.94e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADRB2—hypertension	6.03e-06	4.87e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP4F12—hypertension	5.96e-06	4.81e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCH1—hypertension	5.96e-06	4.81e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCE—hypertension	5.95e-06	4.81e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FGF2—hypertension	5.92e-06	4.78e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RHOA—hypertension	5.9e-06	4.76e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDGFA—hypertension	5.88e-06	4.75e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VAV3—hypertension	5.88e-06	4.75e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PIK3R1—hypertension	5.84e-06	4.72e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOS3—hypertension	5.84e-06	4.72e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—FOS—hypertension	5.83e-06	4.71e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—hypertension	5.83e-06	4.71e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFBR2—hypertension	5.8e-06	4.68e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—NOTCH1—hypertension	5.78e-06	4.67e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GNB3—hypertension	5.74e-06	4.64e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLCD1—hypertension	5.71e-06	4.61e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AVP—hypertension	5.66e-06	4.58e-05	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—EGFR—hypertension	5.65e-06	4.57e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—AKT2—hypertension	5.6e-06	4.52e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GNAS—hypertension	5.59e-06	4.52e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MYC—hypertension	5.53e-06	4.46e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—hypertension	5.51e-06	4.45e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP11B1—hypertension	5.5e-06	4.44e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AHCY—hypertension	5.5e-06	4.44e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—RELA—hypertension	5.49e-06	4.44e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOB—hypertension	5.48e-06	4.42e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTK2—hypertension	5.45e-06	4.4e-05	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—EGFR—hypertension	5.43e-06	4.38e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—EGFR—hypertension	5.4e-06	4.37e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MTOR—hypertension	5.39e-06	4.35e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EDN1—hypertension	5.39e-06	4.35e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL5—hypertension	5.35e-06	4.32e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—INS—hypertension	5.35e-06	4.32e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DBH—hypertension	5.31e-06	4.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALOX12—hypertension	5.31e-06	4.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTM5—hypertension	5.31e-06	4.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EPHX2—hypertension	5.31e-06	4.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GBA—hypertension	5.31e-06	4.29e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LPL—hypertension	5.23e-06	4.22e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—H2AFX—hypertension	5.19e-06	4.19e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDGFRB—hypertension	5.18e-06	4.19e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RPS6KB1—hypertension	5.18e-06	4.19e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL8—hypertension	5.18e-06	4.18e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—AKT2—hypertension	5.17e-06	4.17e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—FGF2—hypertension	5.15e-06	4.16e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2J2—hypertension	5.14e-06	4.15e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADCY5—hypertension	5.12e-06	4.13e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCG—hypertension	5.08e-06	4.11e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—PIK3R1—hypertension	5.08e-06	4.1e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ITGB3—hypertension	5.05e-06	4.08e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCA—hypertension	5.05e-06	4.08e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—YWHAZ—hypertension	5.01e-06	4.05e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—COX5B—hypertension	4.99e-06	4.03e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GLS2—hypertension	4.99e-06	4.03e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ARG1—hypertension	4.99e-06	4.03e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—DECR1—hypertension	4.99e-06	4.03e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SPP1—hypertension	4.95e-06	4e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NGF—hypertension	4.95e-06	4e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—SERPINE1—hypertension	4.91e-06	3.97e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—BCL2—hypertension	4.89e-06	3.95e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR5—hypertension	4.82e-06	3.89e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCD—hypertension	4.82e-06	3.89e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—RELA—hypertension	4.78e-06	3.86e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—FGF2—hypertension	4.75e-06	3.84e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—RHOA—hypertension	4.74e-06	3.83e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALAD—hypertension	4.73e-06	3.82e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HTR2A—hypertension	4.71e-06	3.81e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—C3—hypertension	4.71e-06	3.8e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS3—hypertension	4.69e-06	3.79e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—PIK3R1—hypertension	4.69e-06	3.79e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—hypertension	4.68e-06	3.78e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CDKN1A—hypertension	4.67e-06	3.77e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—PTEN—hypertension	4.66e-06	3.76e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PDGFB—hypertension	4.58e-06	3.7e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGFR1—hypertension	4.56e-06	3.68e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAPK8—hypertension	4.55e-06	3.68e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLCE1—hypertension	4.51e-06	3.65e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALDH7A1—hypertension	4.51e-06	3.65e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—STS—hypertension	4.51e-06	3.65e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—HIF1A—hypertension	4.49e-06	3.63e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AGT—hypertension	4.47e-06	3.61e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EP300—hypertension	4.44e-06	3.59e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CALM1—hypertension	4.4e-06	3.55e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOE—hypertension	4.38e-06	3.54e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LEP—hypertension	4.38e-06	3.54e-05	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—hypertension	4.34e-06	3.51e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CAV1—hypertension	4.34e-06	3.51e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—APOA1—hypertension	4.33e-06	3.5e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP4A11—hypertension	4.33e-06	3.5e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ARG2—hypertension	4.33e-06	3.5e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CBS—hypertension	4.33e-06	3.5e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—hypertension	4.32e-06	3.49e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SRC—hypertension	4.32e-06	3.49e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—KDR—hypertension	4.29e-06	3.47e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—hypertension	4.29e-06	3.46e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—XDH—hypertension	4.24e-06	3.43e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VEGFA—hypertension	4.21e-06	3.4e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP3A5—hypertension	4.17e-06	3.36e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC5A2—hypertension	4.17e-06	3.36e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGIS—hypertension	4.17e-06	3.36e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—hypertension	4.15e-06	3.36e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—F2—hypertension	4.13e-06	3.34e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FN1—hypertension	4.13e-06	3.34e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCB—hypertension	4.13e-06	3.34e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—CDKN1A—hypertension	4.06e-06	3.28e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTEN—hypertension	4.05e-06	3.27e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOTCH1—hypertension	4.04e-06	3.27e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TPH1—hypertension	4.02e-06	3.25e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—UCP2—hypertension	4.02e-06	3.25e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ABCC1—hypertension	4.02e-06	3.25e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HSD11B1—hypertension	4.02e-06	3.25e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—UCP3—hypertension	4.02e-06	3.25e-05	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—AKT1—hypertension	4.01e-06	3.24e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—MAPK8—hypertension	3.96e-06	3.2e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC2A3—hypertension	3.9e-06	3.15e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALAS1—hypertension	3.9e-06	3.15e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP11B2—hypertension	3.9e-06	3.15e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MYC—hypertension	3.87e-06	3.13e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—EP300—hypertension	3.86e-06	3.12e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—hypertension	3.86e-06	3.12e-05	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—AKT1—hypertension	3.85e-06	3.11e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HSD3B1—hypertension	3.84e-06	3.1e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADA—hypertension	3.84e-06	3.1e-05	CbGpPWpGaD
Everolimus—FKBP1A—Disease—AKT1—hypertension	3.83e-06	3.1e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—EGFR—hypertension	3.78e-06	3.06e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AQP1—hypertension	3.78e-06	3.06e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—FADS1—hypertension	3.78e-06	3.06e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—POMC—hypertension	3.76e-06	3.04e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—SRC—hypertension	3.76e-06	3.03e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—CDKN1A—hypertension	3.75e-06	3.03e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—INS—hypertension	3.74e-06	3.02e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—PTEN—hypertension	3.74e-06	3.02e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL2—hypertension	3.68e-06	2.98e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TBXAS1—hypertension	3.68e-06	2.97e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CA9—hypertension	3.68e-06	2.97e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IGF1—hypertension	3.62e-06	2.93e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AKT2—hypertension	3.62e-06	2.92e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALOX15—hypertension	3.59e-06	2.9e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALOX5AP—hypertension	3.59e-06	2.9e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—EP300—hypertension	3.57e-06	2.88e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LHB—hypertension	3.5e-06	2.83e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HADHA—hypertension	3.5e-06	2.83e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—SRC—hypertension	3.47e-06	2.8e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SERPINE1—hypertension	3.44e-06	2.78e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LPA—hypertension	3.42e-06	2.76e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HSD3B2—hypertension	3.42e-06	2.76e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—KCNJ11—hypertension	3.42e-06	2.76e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FGF2—hypertension	3.33e-06	2.69e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RHOA—hypertension	3.32e-06	2.68e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—EGFR—hypertension	3.29e-06	2.66e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PIK3R1—hypertension	3.28e-06	2.65e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOS3—hypertension	3.28e-06	2.65e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LRP2—hypertension	3.28e-06	2.65e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP2C18—hypertension	3.28e-06	2.65e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—hypertension	3.18e-06	2.57e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HSPG2—hypertension	3.16e-06	2.55e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—MYC—hypertension	3.11e-06	2.51e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—hypertension	3.1e-06	2.5e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RELA—hypertension	3.09e-06	2.5e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALOX5—hypertension	3.05e-06	2.46e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GLP1R—hypertension	3.05e-06	2.46e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—EGFR—hypertension	3.04e-06	2.46e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL8—hypertension	2.91e-06	2.35e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—hypertension	2.91e-06	2.35e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALDH2—hypertension	2.79e-06	2.25e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HBA1—hypertension	2.72e-06	2.2e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP11A1—hypertension	2.7e-06	2.18e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—AKT1—hypertension	2.68e-06	2.17e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC9A1—hypertension	2.65e-06	2.14e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTT1—hypertension	2.65e-06	2.14e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—hypertension	2.63e-06	2.13e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CDKN1A—hypertension	2.62e-06	2.12e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCLC—hypertension	2.62e-06	2.12e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CETP—hypertension	2.62e-06	2.12e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTEN—hypertension	2.62e-06	2.12e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAPK8—hypertension	2.56e-06	2.07e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—hypertension	2.53e-06	2.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP17A1—hypertension	2.51e-06	2.03e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EP300—hypertension	2.5e-06	2.02e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS1—hypertension	2.49e-06	2.01e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ENO1—hypertension	2.49e-06	2.01e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SRC—hypertension	2.43e-06	1.96e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CTGF—hypertension	2.39e-06	1.93e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT2—hypertension	2.37e-06	1.92e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HMGCR—hypertension	2.37e-06	1.92e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VEGFA—hypertension	2.37e-06	1.91e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—hypertension	2.34e-06	1.89e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—AKT1—hypertension	2.33e-06	1.89e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADRA2A—hypertension	2.32e-06	1.87e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MYC—hypertension	2.18e-06	1.76e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—TH—hypertension	2.17e-06	1.75e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—hypertension	2.17e-06	1.75e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CALM2—hypertension	2.16e-06	1.75e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—AKT1—hypertension	2.16e-06	1.74e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—EGFR—hypertension	2.13e-06	1.72e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC2A4—hypertension	2.11e-06	1.71e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GCG—hypertension	2.11e-06	1.71e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GOT1—hypertension	2.05e-06	1.65e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—STK11—hypertension	1.99e-06	1.61e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP19A1—hypertension	1.99e-06	1.61e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—COMT—hypertension	1.85e-06	1.49e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARGC1A—hypertension	1.82e-06	1.47e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GNB3—hypertension	1.82e-06	1.47e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—HMOX1—hypertension	1.81e-06	1.46e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAT—hypertension	1.79e-06	1.45e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—hypertension	1.79e-06	1.44e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GNAS—hypertension	1.77e-06	1.43e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOB—hypertension	1.74e-06	1.4e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GSTM1—hypertension	1.69e-06	1.36e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—LPL—hypertension	1.66e-06	1.34e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—hypertension	1.64e-06	1.32e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ADCY5—hypertension	1.62e-06	1.31e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GPX1—hypertension	1.62e-06	1.31e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PRKCA—hypertension	1.6e-06	1.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CYP1A1—hypertension	1.6e-06	1.29e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CD36—hypertension	1.58e-06	1.27e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—AKT1—hypertension	1.51e-06	1.22e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MTHFR—hypertension	1.49e-06	1.21e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARA—hypertension	1.46e-06	1.18e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AGT—hypertension	1.42e-06	1.15e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CALM1—hypertension	1.39e-06	1.13e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOE—hypertension	1.39e-06	1.12e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAV1—hypertension	1.38e-06	1.11e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—APOA1—hypertension	1.37e-06	1.11e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PPARG—hypertension	1.21e-06	9.78e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—POMC—hypertension	1.19e-06	9.65e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—INS—hypertension	1.19e-06	9.59e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—hypertension	1.09e-06	8.79e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PIK3R1—hypertension	1.04e-06	8.41e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NOS3—hypertension	1.04e-06	8.41e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—hypertension	9.52e-07	7.69e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTEN—hypertension	8.31e-07	6.71e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—EP300—hypertension	7.92e-07	6.4e-06	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—AKT1—hypertension	4.79e-07	3.87e-06	CbGpPWpGaD
